Written and maintained by CASRAI Editorial Board
Published
This page describes products and general use; it is not medical advice.
On this page
Short answer
SoloSite is a sterile, amorphous hydrogel wound dressing formulated with purified water, glycerin, and sodium carboxymethylcellulose to support moist wound healing and facilitate autolytic debridement. Regulated under FDA 21 CFR 878.4022 as a Class I medical device, it rehydrates dry slough and necrotic tissue while absorbing light exudate across minor burns, superficial lacerations, and chronic ulcers.
Definition and scope
SoloSite Wound Gel is an amorphous hydrogel wound dressing manufactured by Smith and Nephew. The U.S. Food and Drug Administration (FDA) classifies amorphous hydrogels under 21 CFR 878.4022 as Class I medical devices under product code NAE (Dressing, Wound, Hydrogel Without Drug And/Or Biologic), with historical 510(k) clearances including K932263 and K981150. In Global Medical Device Nomenclature (GMDN), it is cataloged under code 47764 as a non-antimicrobial wound hydrogel dressing.
Unlike fixed sheet dressings, an amorphous hydrogel wound dressing has no fixed shape. It is supplied as a clear, viscous gel that conforms directly to uneven wound surfaces, cavities, and undermined margins within standard medical dressing classifications.
SoloSite is distributed in 3-ounce (85 g) multi-dose flip-top tubes (catalog number 449600) and gel-impregnated gauze pads. The chemical composition combines an aqueous base with functional polymers and humectants:
- Purified Water (greater than 60%): Donates moisture directly to desiccated tissue.
- USP Glycerin (10% to 25%): Retains moisture in the wound bed and resists drying.
- Sodium Carboxymethylcellulose (1% to 10%): Forms the polymer matrix and provides minor exudate absorption.
- Allantoin (less than 1%): Skin-conditioning compound that soothes periwound skin.
- Preservatives: Benzyl alcohol, methylparaben, and propylparaben inhibit microbial growth in multi-dose tubes.
How it works or how it is used in practice
SoloSite supports moist wound healing through two physical actions:
- Moisture Donation and Autolytic Debridement: High water content diffuses into dry eschar and slough. By rehydrating non-viable tissue, the gel softens debris and allows endogenous enzymes to break down necrotic tissue. Unlike chemical or enzymatic debridement agents that digest tissue via exogenous enzymes, amorphous hydrogels facilitate natural autolysis.
- Fluid Uptake and Viscosity Retention: Sodium carboxymethylcellulose chains swell on contact with fluid, absorbing minor exudate while maintaining gel structure.
SoloSite is indicated for minor burns, superficial lacerations, cuts, abrasions, skin tears, and chronic wounds including Stage I to IV pressure injuries, diabetic foot ulcers, and venous stasis ulcers. Clinicians apply the gel across the wound bed at roughly 5 mm depth. Because amorphous hydrogels provide no mechanical barrier, clinicians must apply a secondary dressing—such as a transparent film, non-adherent pad, or foam. For bioburden management, clinicians also contrast pure hydrogels with surfactant wound gels such as PluroGel vs hydrogel formulations.
Dressings are changed every 24 to 72 hours based on drainage. Residual gel rinses away with sterile saline irrigation, protecting new granulation tissue from trauma.
Types or related concepts
Amorphous hydrogels share therapeutic goals, but formulations vary by base polymers, humectants, delivery systems, and preservative profiles. The table below compares four commercial amorphous hydrogels based on FDA filings and manufacturer specifications.
| Product | Manufacturer | Primary Formulation | Delivery Format | FDA Code and Class | Key Clinical Consideration |
|---|---|---|---|---|---|
| SoloSite | Smith and Nephew | Purified water, glycerin (10%–25%), sodium carboxymethylcellulose, allantoin | Multi-dose flip-top tube (3 oz / 85 g) | NAE / 21 CFR 878.4022 (Class I) | Glycerin-based humectant; multi-dose tube discarded 3 months after opening. |
| IntraSite Gel | Smith and Nephew | Purified water, propylene glycol (~20%), modified carboxymethylcellulose | Single-dose Applipak nozzle (15 g, 25 g) | NAE / 21 CFR 878.4022 (Class I) | Direct cavity nozzle; contraindicated with known propylene glycol sensitivity. |
| Normlgel | Mölnlycke Health Care | 0.9% Sodium chloride (isotonic saline), purified water, xanthan gum | Single-dose and multi-dose tubes | MGQ / 510(k) K984368 (Class I) | Isotonic formula using 0.9% sodium chloride; free from synthetic humectants. |
| Curasol | Healthpoint / DPT Labs | Aqueous polymer hydrogel matrix, aloe vera, glycerin | Multi-dose squeeze tubes | MGQ / 510(k) K953450 (Class I) | Viscous clear gel for gentle cavity filling and slough rehydration. |
Clinicians also distinguish amorphous gels from sheet hydrogels and hydrocolloids. While sheet dressings suit flat, minimally exuding wounds, amorphous gels suit irregular cavitary wounds. Clinicians can review moisture-retentive polymers in hydrogel vs hydrocolloid dressings.
Where it matters for labs, clinics or supply decisions
Supply managers and clinical supervisors evaluate several operational factors when managing amorphous hydrogels:
- HCPCS Reimbursement Coding: In outpatient and durable medical equipment (DME) billing, amorphous hydrogel wound fillers are billed under HCPCS code A6248 (Hydrogel dressing, wound filler, gel, per fluid ounce). A standard 3-ounce tube represents 3 billing units.
- Multi-Dose Expiration and Waste: SoloSite is packaged in multi-dose tubes for single-patient use. Instructions specify discarding opened tubes three months after opening. High-turnover clinics record the opening date; low-volume clinics often prefer single-dose dispensers (such as IntraSite Applipak) to minimize waste.
- Secondary Dressing Pairing: SoloSite requires a secondary dressing: transparent films for low exudate, and absorbent foams or bordered gauze for moderate exudate.
- Storage and Temperature: Store SoloSite at room temperature between 15°C and 30°C (59°F and 86°F). Avoid freezing to prevent phase separation.
- Biomedical Research: In animal studies and tissue models, SoloSite serves as a non-cytotoxic hydrating agent for maintaining moist conditions during observation and burn trials.
Common misunderstandings
Several misconceptions surround the clinical role and handling of SoloSite:
- Misconception 1: SoloSite is an antimicrobial gel. SoloSite is a non-antimicrobial hydrogel (GMDN 47764). Preservatives prevent contamination inside the tube, not in the wound bed. It contains no silver, iodine, or PHMB. Infected wounds require systemic or dedicated antimicrobial therapy.
- Misconception 2: SoloSite is suitable for heavy exudate. Amorphous hydrogels are moisture donors. Placing SoloSite in a heavily draining wound risks periwound maceration.
- Misconception 3: SoloSite contains active chemical debriding enzymes. SoloSite supports autolytic debridement by maintaining moisture that enables endogenous host enzymes. It contains no exogenous enzymes like collagenase.
- Misconception 4: Multi-dose tubes can be shared across patients. SoloSite tubes are designated strictly for single-patient use to prevent cross-contamination.
Frequently asked questions
Does SoloSite require a secondary dressing?
Yes. SoloSite is an amorphous gel without an adhesive border or protective backing. A secondary dressing—such as transparent film, gauze, or foam—must be applied over the gel to secure it and prevent evaporation.
How does SoloSite differ from IntraSite Gel?
While both are amorphous hydrogels made by Smith and Nephew, SoloSite uses a glycerin and allantoin formulation in multi-dose tubes, whereas IntraSite Gel uses a propylene glycol formulation in single-use Applipak dispensers. IntraSite is contraindicated in patients with known propylene glycol allergies.
What is the HCPCS billing code for SoloSite?
SoloSite is billed under HCPCS code A6248 (Hydrogel dressing, wound filler, gel, per fluid ounce). Billing units correspond to the fluid ounce volume dispensed.
Can SoloSite be used on dry necrotic eschar?
Yes. Rehydrating dry, hard eschar and slough is a primary clinical use for amorphous hydrogels. The gel donates water to soften necrotic tissue, supporting natural autolytic debridement.
How long is a tube of SoloSite good for after opening?
Manufacturer guidelines dictate that a multi-dose tube of SoloSite should be discarded three months after opening or upon reaching the printed expiration date, whichever comes first.
Sources
- U.S. Food and Drug Administration. 510(k) Premarket Notification K932263: SOLOSITE Dermal Wound Gel. Rockville, MD: FDA; cleared October 1, 1993. Checked November 8, 2026.
- U.S. Food and Drug Administration. 510(k) Premarket Notification K981150: SOLOSITE Gel Conformable Dressing. Rockville, MD: FDA; cleared May 18, 1998. Checked November 8, 2026.
- U.S. Food and Drug Administration. Unique Device Identification (UDI) System: SOLOSITE Wound Gel (DI 00040565115276). 21 CFR 878.4022. Silver Spring, MD: FDA AccessGUDID; verified November 8, 2026.
- Smith and Nephew Medical Ltd. Instructions for Use: SOLOSITE Hydrogel Wound Dressing. Hull, UK: Smith and Nephew; 2023. Checked November 8, 2026.
- Centers for Medicare and Medicaid Services. Healthcare Common Procedure Coding System (HCPCS) Level II Code A6248: Hydrogel dressing, wound filler, gel, per fluid ounce. Baltimore, MD: CMS; 2026. Checked November 8, 2026.
- U.S. Food and Drug Administration. 510(k) Premarket Notification K891870: INTRASITE Gel. Rockville, MD: FDA; cleared May 1989. Checked November 8, 2026.
- U.S. Food and Drug Administration. 510(k) Premarket Notification K984368: NORMLGEL 0.9% Isotonic Saline Gel. Rockville, MD: FDA; cleared December 1998. Checked November 8, 2026.







